FDA Approves First mRNA-Based Flu Vaccine for Older Adults
Sourced from 6 publications
- •The FDA approved Moderna's mRNA flu vaccine for adults aged 50 and older, the first mRNA vaccine authorized for seasonal influenza.
- •The mRNA platform enables faster production and easier strain matching compared to traditional egg-based or cell-based flu vaccine manufacturing.
- •COVID-19 cases are rising in 43 states, with California's infection pattern gradually shifting toward summer peaks over recent years.
- •President Trump ordered combination vaccines including MMR to be separated into individual shots, reversing a practice standard for decades.
Sources
Winter is coming: How vaccines help protect against respiratory illness
Medicalxpress
The FDA approved the first mRNA flu vaccine for use in older adults. Here’s what...
CNN
Summer is now California's COVID busy season as winter waves fade
Los Angeles Times
Trump's vaccine order would require millions of individual shots last used decad...
PBS NewsHour
Is there a summer COVID-19 surge this year? Yep, it's ramping up again
NPR News
SAVC calls for tighter farm biosecurity before disease outbreaks
foodformzansi.co.za
Curated from 6 sources. Every summary is reviewed for accuracy, but may still contain errors. We always link to original sources for verification.
Related Stories
About Meridian
Meridian is a free daily newsletter delivering signal-scored news stories with forward-looking analysis every morning. Stories are scored across six criteria (global leverage, capital impact, temporal durability, career relevance, decision utility, and narrative clarity) then assigned to Big Signal, Core, or Quick tiers.
Get Meridian in your inbox
The stories that matter, every morning at 06:00.